By Robert Preidt
THURSDAY, Sept. 28, 2017 (HealthDay Information) — The primary fingerstick-free blood sugar monitoring system for adults with diabetes has been authorized by the U.S. Meals and Drug Administration.
The FreeStyle Libre Flash Glucose Monitoring System incorporates a small sensor wire that is positioned beneath the pores and skin’s floor and constantly screens blood sugar (glucose) ranges. Folks with diabetes can wave a cell reader above the sensor wire to examine their glucose ranges.
The system is authorized to be used in folks with diabetes aged 18 and older. After a 12-hour start-up interval, it may be worn for as much as 10 days, the FDA stated.
“This method permits folks with diabetes to keep away from the extra step of fingerstick calibration, which may typically be painful, however nonetheless offers mandatory data for treating their diabetes — with a wave of the cell reader,” Donald St. Pierre stated in an FDA information launch. He’s deputy director of recent product analysis within the FDA’s Middle for Gadgets and Radiological Well being.
Approval of the system, made by Abbott Diabetes Care, was primarily based on a medical trial of diabetes sufferers aged 18 and older.
The system doesn’t present real-time alerts by itself, the FDA famous. For instance, it can not warn sufferers about low blood glucose ranges whereas they’re sleeping.
Potential dangers related to the system embrace low or excessive blood sugar if knowledge it offers is inaccurate and used to make therapy choices, the FDA stated. Some sufferers may additionally have delicate pores and skin irritation across the space the place the sensor wire is inserted.
Greater than 29 million folks in the USA have diabetes, in accordance with the U.S. Facilities for Illness Management and Prevention.
Folks with diabetes both do not make sufficient insulin (sort 1 diabetes) or can not use insulin correctly (sort 2 diabetes). When the physique does not have sufficient insulin or cannot use it successfully, sugar builds up within the blood. Excessive blood sugar ranges can result in coronary heart illness; stroke; blindness; kidney failure; and amputation of toes, ft or leg, in accordance with background data within the FDA information launch.